Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Exploring Genetic Links Between EBV Clearance and MS Risk
The New Era of Targeted Therapy for Myasthenia Gravis
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
Discharge Planning After Myasthenic Crisis
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
More Than a Myopathy: The Lived Experience of TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.